{
  "id": "NGN-SA-2026-B300S36-3281",
  "questionType": "bowtie",
  "caseId": "B300S36-MDD",
  "itemStem": "A 48-year-old male client presents to the outpatient mental health clinic for a follow-up appointment. He was diagnosed with major depressive disorder six weeks ago and started on sertraline 50 mg daily. The client states, \"I'm not crying all the time anymore, but something feels off. I have so much energy now, I only need 3 hours of sleep!\" He reports maxing out two credit cards on a new home theater system last week, stating, \"It was an amazing deal, I had to do it!\" During the interview, the nurse notes the client speaks rapidly, jumping from one topic to another. His wife called the clinic earlier, expressing concern about his \"erratic and impulsive\" behavior.",
  "options": {
    "conditions": [
      {
        "id": "C1",
        "text": "Serotonin syndrome"
      },
      {
        "id": "C2",
        "text": "Neuroleptic malignant syndrome"
      },
      {
        "id": "C3",
        "text": "Antidepressant-induced hypomania"
      },
      {
        "id": "C4",
        "text": "Successful treatment of depression"
      },
      {
        "id": "C5",
        "text": "Worsening depressive episode with anxious distress"
      }
    ],
    "actions": [
      {
        "id": "A1",
        "text": "Educate the client on the importance of medication adherence."
      },
      {
        "id": "A2",
        "text": "Place the client on immediate suicide and safety precautions."
      },
      {
        "id": "A3",
        "text": "Recommend increasing the sertraline dose to 100 mg daily."
      },
      {
        "id": "A4",
        "text": "Notify the prescribing healthcare provider of the client's change in status."
      },
      {
        "id": "A5",
        "text": "Schedule a routine follow-up appointment in one month."
      }
    ],
    "parameters": [
      {
        "id": "P1",
        "text": "Sleep patterns"
      },
      {
        "id": "P2",
        "text": "Serum creatinine levels"
      },
      {
        "id": "P3",
        "text": "Impulsive or high-risk behaviors"
      },
      {
        "id": "P4",
        "text": "Mood and affect"
      },
      {
        "id": "P5",
        "text": "Daily caloric intake"
      }
    ]
  },
  "answers": [
    {
      "condition": "C3",
      "actions": [
        "A2",
        "A4"
      ],
      "parameters": [
        "P1",
        "P3",
        "P4"
      ]
    }
  ],
  "answerBreakdown": {
    "conditionRationale": {
      "C1": "Incorrect. Serotonin syndrome results from excessive serotonin activity in the central nervous system and peripheral nervous system. Key symptoms include mental status changes (agitation, confusion), autonomic instability (tachycardia, hyperthermia, diaphoresis), and neuromuscular abnormalities (tremor, hyperreflexia, myoclonus). While the client exhibits some mental status changes, the absence of autonomic and neuromuscular symptoms rules out serotonin syndrome.",
      "C2": "Incorrect. Neuroleptic malignant syndrome (NMS) is a rare, life-threatening reaction to antipsychotic medications or dopamine-blocking agents. The cardinal features of NMS are fever, muscle rigidity (often described as 'lead pipe' rigidity), altered mental status, and autonomic dysfunction (tachycardia, labile blood pressure, diaphoresis). This client is not taking antipsychotics, making NMS highly unlikely.",
      "C3": "Correct. The client's presentation strongly suggests antidepressant-induced hypomania. Hypomania is a distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased activity or energy, lasting at least 4 consecutive days. Three or more of the following symptoms are present: inflated self-esteem or grandiosity, decreased need for sleep, more talkative than usual or pressure to keep talking, flight of ideas or racing thoughts, distractibility, increase in goal-directed activity or psychomotor agitation, and excessive involvement in activities that have a high potential for painful consequences (e.g., engaging in unrestrained buying sprees). The temporal relationship with sertraline initiation is crucial. This unmasks a potential bipolar spectrum disorder.",
      "C4": "Incorrect. While the client reports some improvement in depressive symptoms (less crying), the emergence of new symptoms such as decreased need for sleep, increased energy, pressured speech, and impulsive spending indicates a significant adverse effect of the antidepressant, not successful treatment of depression. Successful treatment would involve resolution of depressive symptoms without the emergence of manic or hypomanic symptoms.",
      "C5": "Incorrect. A worsening depressive episode with anxious distress would primarily manifest as increased sadness, hopelessness, loss of interest, and anxiety symptoms such as excessive worry, restlessness, and difficulty concentrating. The client's elevated mood, decreased need for sleep, and impulsive behavior are inconsistent with a worsening depressive episode. Anxious distress can co-occur with depression, but it does not explain the hypomanic symptoms."
    },
    "actionsRationale": {
      "A1": "Incorrect. While medication adherence is generally important, the client's current presentation suggests an adverse reaction to the medication. Educating the client on adherence without addressing the underlying hypomanic symptoms could be detrimental and potentially worsen the condition. The priority is to assess and manage the hypomania.",
      "A2": "Correct. The client's impulsive behavior, poor judgment, and potential grandiosity significantly increase the risk for harm to self or others. The client's recent spending spree and decreased need for sleep suggest impaired judgment and impulse control. A thorough safety assessment, including assessment for suicidal and homicidal ideation, is an immediate priority. Implementing suicide and safety precautions is warranted until the client is stabilized and deemed safe.",
      "A3": "Incorrect. Increasing the dose of sertraline, an SSRI, would likely exacerbate the hypomanic symptoms and is contraindicated. SSRIs can trigger manic or hypomanic episodes in individuals with underlying bipolar disorder. The priority is to discontinue the offending agent and consider mood-stabilizing medications.",
      "A4": "Correct. The client's change in status, characterized by the emergence of hypomanic symptoms after starting sertraline, requires immediate re-evaluation by the prescribing healthcare provider. The provider needs to assess the client for bipolar disorder and adjust the treatment plan accordingly. This may involve discontinuing the sertraline and initiating a mood stabilizer. Delaying notification could lead to escalation of the hypomanic episode and potential harm to the client.",
      "A5": "Incorrect. The client's condition is acute and requires immediate intervention to ensure safety and prevent escalation to full mania. A one-month delay is unsafe and inappropriate. The client needs to be assessed and treated promptly to prevent further complications and potential harm. A follow-up appointment should be scheduled much sooner, typically within a few days, to monitor the client's response to treatment changes."
    },
    "parametersRationale": {
      "P1": "Correct. A decreased need for sleep is a core symptom of hypomania. Monitoring sleep patterns is essential to track the client's response to treatment. A return to a normal sleep duration would be a key indicator of stabilization. The nurse should assess the client's sleep duration, quality, and any use of sleep aids.",
      "P2": "Incorrect. Serum creatinine levels assess kidney function. While important for some psychiatric medications like lithium, it is not a direct or priority parameter to monitor for this client's acute presentation of hypomania. Kidney function is not directly related to the client's current symptoms.",
      "P3": "Correct. The client has already demonstrated significant impulsive behavior (excessive spending). Continued monitoring for such behaviors (e.g., reckless driving, financial indiscretion, risky sexual encounters) is critical for patient safety. The nurse should inquire about any other impulsive behaviors the client may be engaging in.",
      "P4": "Correct. The primary problem is mood dysregulation. The nurse must closely monitor the client's mood (subjective feeling) and affect (objective expression) for signs of continued elevation, irritability, or a switch back to depression. The nurse should document the client's mood and affect at each encounter.",
      "P5": "Incorrect. While appetite can be affected in mood disorders, daily caloric intake is not a primary parameter to monitor in this acute hypomanic state unless there is a significant, co-occurring issue like severe weight loss or nutritional deficiency. The focus should be on managing the mood dysregulation and preventing harm."
    },
    "clinicalPearls": "*   **Antidepressant-induced mania/hypomania:** Always consider the possibility of antidepressant-induced mania or hypomania, especially when a patient presents with new-onset manic symptoms after starting an antidepressant. This is particularly important in patients with a family history of bipolar disorder.\n*   **Bipolar Disorder Screening:** Screen patients for bipolar disorder before initiating antidepressant therapy. Tools like the Mood Disorder Questionnaire (MDQ) can be helpful.\n*   **Safety First:** Prioritize patient safety when assessing a patient with suspected mania or hypomania. Assess for suicidal and homicidal ideation, and implement appropriate safety precautions.\n*   **SBAR Communication:** Use SBAR to communicate effectively with the healthcare provider about the client's change in status.\n*   **Medication Review:** Always review the patient's medication list to identify potential drug interactions or adverse effects.\n*   **Family Input:** Obtain information from family members or significant others, as they can provide valuable insights into the patient's behavior and symptoms.\n*   **Differential Diagnosis:** Consider other potential causes of manic symptoms, such as substance abuse, medical conditions, or other psychiatric disorders.\n*   **Documentation:** Document all findings, interventions, and communication with the healthcare provider in the patient's medical record."
  },
  "meta": {
    "topic": "Major Depressive Disorder",
    "difficulty": 4,
    "cjmm": "Take Actions",
    "clientAge": "48-year-old",
    "setting": "Outpatient Clinic",
    "seed": "BATCH-300-36-1771345467273",
    "SBAR": {
      "situation": "48-year-old male, diagnosed with MDD 6 weeks ago, on sertraline 50mg daily, presents with increased energy, decreased sleep (3 hours), and impulsive spending. Wife reports \"erratic and impulsive\" behavior.",
      "background": "Client was diagnosed with MDD and started on sertraline 6 weeks ago. He reports improvement in depressive symptoms (less crying) but now experiences new symptoms.",
      "assessment": "Client exhibits signs of antidepressant-induced hypomania: elevated energy, decreased need for sleep, pressured speech, and impulsive spending. Potential risk for harm to self or others due to impaired judgment.",
      "recommendation": "Recommend immediate notification of the prescribing healthcare provider. Place the client on suicide and safety precautions. Monitor sleep patterns, mood, affect, and impulsive behaviors closely. Consider discontinuing sertraline and evaluating for bipolar disorder. Schedule a follow-up appointment within a few days to monitor response to treatment changes.",
      "time": "1400"
    }
  },
  "sentinelStatus": "healed_v2026_v8"
}